State Street SPDR S&P Biotech ETFXBI
Closing prices as of Sep 15, 2026Updated once daily after the US close — not a live quote.

$154.10

-1.98% past month

Notable price movement

  • Sep 15, 2026

    $154.03-2.27%

    XBI fell 2.27%, a decline not shared by the broad market, which moved just -0.46% the same session .

  • Sep 14, 2026

    $157.60+0.90%

  • Sep 11, 2026

    $156.20-0.40%

  • Sep 10, 2026

    $156.82-1.61%

  • Sep 9, 2026

    $159.38-1.57%

  • Sep 8, 2026

    $161.93-1.15%

  • Sep 4, 2026

    $163.81-0.35%

Closing prices for XBI. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Recent news

Seeking AlphaSep 5, 2026XBI: Big Pharma Can Keep The 76% Rally GoingThe Motley FoolAug 22, 2026Breakfast News: A Conversation With Ionis CEOEtf TrendsJul 17, 2026Healthcare Rules State Street’s Top 5 ETFs in Past Month24/7 Wall StJul 6, 2026This ETF Is Up Nearly 17% in a Month and Doesn’t Own a Single Share of NvidiaSeeking AlphaSep 3, 2026The Market May Be Telling Us We're Entering A Capital Formation CycleThe Motley FoolAug 20, 2026IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.

Prices and financial data are historical and provided for research only. Not investment advice.